95 related articles for article (PubMed ID: 9920822)
1. Structure-activity relationship study of steroidal and nonsteroidal inhibitors of the enzyme estrone sulfatase.
Ahmed S; James K; Sampson L; Mastri C
Biochem Biophys Res Commun; 1999 Jan; 254(3):811-5. PubMed ID: 9920822
[TBL] [Abstract][Full Text] [Related]
2. The design, synthesis, and biochemical evaluation of derivatives of biphenyl sulfamate-based compounds as novel inhibitors of estrone sulfatase.
Ahmed S; James K; Owen CP
Biochem Biophys Res Commun; 2002 May; 294(1):180-3. PubMed ID: 12054760
[TBL] [Abstract][Full Text] [Related]
3. Estrone sulfatase: probing structural requirements for substrate and inhibitor recognition.
Anderson C; Freeman J; Lucas LH; Farley M; Dalhoumi H; Widlanski TS
Biochemistry; 1997 Mar; 36(9):2586-94. PubMed ID: 9054565
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationship determination within a group of substituted phenyl sulfamate based compounds against the enzyme oestrone sulfatase.
Patel CK; Galisson A; James K; Owen CP; Ahmed S
J Pharm Pharmacol; 2003 Feb; 55(2):211-8. PubMed ID: 12631414
[TBL] [Abstract][Full Text] [Related]
5. Dual aromatase-sulfatase inhibitors based on the anastrozole template: synthesis, in vitro SAR, molecular modelling and in vivo activity.
Jackson T; Woo LW; Trusselle MN; Chander SK; Purohit A; Reed MJ; Potter BV
Org Biomol Chem; 2007 Sep; 5(18):2940-52. PubMed ID: 17728860
[TBL] [Abstract][Full Text] [Related]
6. Determination and use of a transition state for the enzyme estrone sulfatase (ES) from a proposed reaction mechanism.
Ahmed S; James K; Owen CP; Patel CK; Patel MB
Bioorg Med Chem Lett; 2001 Dec; 11(23):3001-5. PubMed ID: 11714597
[TBL] [Abstract][Full Text] [Related]
7. Stilbene-based inhibitors of estrone sulfatase with a dual mode of action in human breast cancer cells.
Walter G; Liebl R; von Angerer E
Arch Pharm (Weinheim); 2004 Dec; 337(12):634-44. PubMed ID: 15597397
[TBL] [Abstract][Full Text] [Related]
8. Development of (p-O-sulfamoyl)-N-alkanoyl-phenylalkyl amines as non-steroidal estrone sulfatase inhibitors.
Kolli A; Chu GH; Rhodes ME; Inoue K; Selcer KW; Li PK
J Steroid Biochem Mol Biol; 1999 Jan; 68(1-2):31-40. PubMed ID: 10215035
[TBL] [Abstract][Full Text] [Related]
9. The mechanism of the irreversible inhibition of estrone sulfatase (ES) through the consideration of a range of methane- and amino-sulfonate-based compounds.
Ahmed S; James K; Owen CP; Patel CK; Sampson L
Bioorg Med Chem Lett; 2002 May; 12(9):1279-82. PubMed ID: 11965370
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological activity of the superestrogen (E)-17-oximino-3-O-sulfamoyl-1,3,5(10)-estratriene: x-ray crystal structure of (E)-17-oximino-3-hydroxy-1,3,5(10)-estratriene.
Hejaz HA; Purohit A; Mahon MF; Reed MJ; Potter BV
J Med Chem; 1999 Aug; 42(16):3188-92. PubMed ID: 10447965
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biochemical evaluation of AC ring mimics as novel inhibitors of the enzyme estrone sulfatase (ES).
Ahmed S; James K; Owen CP
J Steroid Biochem Mol Biol; 2002 Nov; 82(4-5):425-35. PubMed ID: 12589950
[TBL] [Abstract][Full Text] [Related]
12. Hydrophobicity, a physicochemical factor in the inhibition of the enzyme estrone sulfatase (ES).
Ahmed S; James K; Owen CP; Patel CK; Patel M
Bioorg Med Chem Lett; 2001 Sep; 11(18):2525-8. PubMed ID: 11549461
[TBL] [Abstract][Full Text] [Related]
13. Estrone sulfonates as inhibitors of estrone sulfatase.
Howarth NM; Purohit A; Reed MJ; Potter BV
Steroids; 1997 Apr; 62(4):346-50. PubMed ID: 9090794
[TBL] [Abstract][Full Text] [Related]
14. First report of the investigation into the importance of pK(a) in the inhibition of estrone sulfatase by sulfamate containing compounds.
Ahmed S; James K; Patel CK
Biochem Biophys Res Commun; 2000 Jun; 272(2):583-5. PubMed ID: 10833455
[TBL] [Abstract][Full Text] [Related]
15. Derivation of a possible transition-state for the reaction catalysed by the enzyme estrone Sulfatase (ES).
Ahmed S; James K
Bioorg Med Chem Lett; 1999 Jun; 9(12):1645-50. PubMed ID: 10397493
[TBL] [Abstract][Full Text] [Related]
16. 17 alpha-alkyl- or 17 alpha-substituted benzyl-17 beta-estradiols: a new family of estrone-sulfatase inhibitors.
Poirier D; Boivin RP
Bioorg Med Chem Lett; 1998 Jul; 8(14):1891-6. PubMed ID: 9873454
[TBL] [Abstract][Full Text] [Related]
17. Boronic acids as inhibitors of steroid sulfatase.
Ahmed V; Liu Y; Silvestro C; Taylor SD
Bioorg Med Chem; 2006 Dec; 14(24):8564-73. PubMed ID: 16973364
[TBL] [Abstract][Full Text] [Related]
18. Steroidal oxathiazine inhibitors of estrone sulfatase.
Peters RH; Chao WR; Sato B; Shigeno K; Zaveri NT; Tanabe M
Steroids; 2003 Jan; 68(1):97-110. PubMed ID: 12475726
[TBL] [Abstract][Full Text] [Related]
19. The derivation of a potential transition state for the reduction reaction catalysed by 17beta-hydroxysteroid dehydrogenase--an approximate representation of its active site for use in drug design and discovery.
Owen CP; Ahmed S
Biochem Biophys Res Commun; 2004 May; 318(1):131-4. PubMed ID: 15110763
[TBL] [Abstract][Full Text] [Related]
20. Dydrogesterone (Duphaston) and its 20-dihydro-derivative as selective estrogen enzyme modulators in human breast cancer cell lines. Effect on sulfatase and on 17beta-hydroxysteroid dehydrogenase (17beta-HSD) activity.
Chetrite GS; Thole HH; Philippe JC; Pasqualini JR
Anticancer Res; 2004; 24(3a):1433-8. PubMed ID: 15274306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
